Related Experiment Video
Updated: Aug 23, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
Comorbidity defines asthmatic patients' risk of COVID-19 hospitalization: A global perspective
Chrysanthi Skevaki1, R Sharon Chinthrajah2, Daria Fomina3
1Institute of Laboratory Medicine and Pathobiochemistry, Philipps University Marburg, Marburg, Germany; Universities of Giessen and Marburg Lung Center (UGMLC), Philipps University Marburg, Marburg, Germany.
Insights
Asthma prevalence varied significantly in hospitalized coronavirus disease 2019 (COVID-19) patients globally. Geographic differences in asthma and COVID-19 co-occurrence are linked to varying comorbidity prevalence, especially chronic obstructive pulmonary disease.
Area of Science:
- Epidemiology
- Pulmonology
- Infectious Diseases
Background:
- Global epidemiology of asthma in COVID-19 patients shows significant geographic variations.
- Prevalence zones of high and low co-occurrence of asthma and COVID-19 are defined.
Purpose of the Study:
- To compare asthma prevalence in hospitalized COVID-19 patients across major global hubs.
- To apply common inclusion criteria and definitions for accurate comparison.
Main Methods:
- A network of 6 academic hospitals was established in the United States, Germany, and Russia.
- Clinical and laboratory data were collected for patients hospitalized with COVID-19.
Main Results:
- Asthmatic patients were overrepresented in the US (Stanford) and underrepresented in Russia (Moscow) and Germany compared to local community prevalence.
- Asthma prevalence did not differ between intensive care unit and non-intensive care unit patients, suggesting no increased risk for severe COVID-19.
- Comorbidities, particularly chronic obstructive pulmonary disease, were more frequent in asthmatic COVID-19 patients in the US cohort.
Conclusions:
- Disparities in COVID-19-associated risk among asthmatic patients are linked to geographic variations in underlying comorbidities.
- Chronic obstructive pulmonary disease prevalence significantly influences the observed differences in asthma and COVID-19 co-occurrence globally.
Background:
The global epidemiology of asthma among patients with coronavirus disease 2019 (COVID-19) presents striking geographic differences, defining prevalence zones of high and low co-occurrence of asthma and COVID-19.
Objective:
We aimed to compare asthma prevalence among hospitalized patients with COVID-19 in major global hubs across the world by applying common inclusion criteria and definitions.
Methods:
We built a network of 6 academic hospitals in Stanford (Stanford University)/the United States; Frankfurt (Goethe University), Giessen (Justus Liebig University), and Marburg (Philipps University)/Germany; and Moscow (Clinical Hospital 52 in collaboration with Sechenov University)/Russia. We collected clinical and laboratory data for patients hospitalized due to COVID-19.
Results:
Asthmatic individuals were overrepresented among hospitalized patients with COVID-19 in Stanford and underrepresented in Moscow and Germany as compared with their prevalence among adults in the local community. Asthma prevalence was similar among patients hospitalized in an intensive care unit and patients hospitalized in other than an intensive care unit, which implied that the risk for development of severe COVID-19 was not higher among asthmatic patients. The numbers of males and comorbidities were higher among patients with COVID-19 in the Stanford cohort, and the most frequent comorbidities among these patients with asthma were other chronic inflammatory airway disorders such as chronic obstructive pulmonary disease.
Conclusion:
The observed disparity in COVID-19-associated risk among asthmatic patients across countries and continents is connected to the varying prevalence of underlying comorbidities, particularly chronic obstructive pulmonary disease.
Related Concept Videos
Asthma-III: Symptoms and Complications
Classification of Asthma
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-I: Introduction
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-IV: Nursing Management
First, in...

